Pancreatic Cancer Research

ResearcherOkayama UniversityActive in the last 2 years

Takuya Fujimoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2161-9526; OpenAlex author ID A5065795682. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug. Co-author DOI 10.1016/j.biomaterials.2024.122605↗
  2. Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes. Co-author DOI 10.3892/ol.2020.12291↗
  3. [A Case of Borderline Resectable Pancreatic Cancer Responding to Preoperative GEM plus Nab-PTX Combination Chemotherapy]. Co-author PMID 28133195↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroyuki Michiue · 1 shared paper, 2024 · strength 0.18
  2. Toshiyoshi Fujiwara · 1 shared paper, 2024 · strength 0.18
  3. Yoshitaro Shindo · 2 shared papers, 2016–2021 · strength 0.16
  4. Nobuaki Suzuki · 2 shared papers, 2016–2021 · strength 0.16
  5. Satoshi Matsukuma · 2 shared papers, 2016–2021 · strength 0.16
  6. Hiroaki Nagano · 2 shared papers, 2016–2021 · strength 0.16
  7. Hiroto Matsui Matsui · 2 shared papers, 2016–2021 · strength 0.16
  8. Yasuhiro Fujiwara · 1 shared paper, 2021 · strength 0.11
  9. Hidetoshi Eguchi · 1 shared paper, 2021 · strength 0.11
  10. Ryouichi Tsunedomi · 1 shared paper, 2021 · strength 0.11
  11. Tomio Ueno · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.